Near-Infrared and Red Light Therapy For Hashimoto’s Hypothyroidism
Several studies have shown profound benefits of photobiomodulation for autoimmune hypothyroidism.
A recent 2013 randomized, placebo-controlled study in hypothyroid patients demonstrated that in people who got near-infrared light therapy, thyroid function dramatically improved, and remarkably, that thyroid antibody (TPOAb) levels were massively reduced. Amazingly, 47% of patients were able to stop medication completely! Moreover, the researchers also followed up 9 months after treatment and found that the effects were still evident!
They even published a 6-year follow-up, which basically said that even at 6 years, some of the benefits still remained, but periodic sessions were recommended to maintain all benefits.
HOFLING, D., et al. (2017) long-term follow-up of patients with hypothyroidism induced by autoimmune thyroiditis submitted to low-level laser therapy
(It is NOT suggested to use red/NIR light as a one-time treatment that is expected to last long-term. For optimal benefits, most research indicates that sessions be done with red/NIR therapy at least once a week consistently.)
A 2010 study found that photobiomodulation helped 38 %of study participants reduce their hypothyroid medication dose, with a whopping 17% being able to stop taking the medication altogether!
A 1997 study done in Russia included some data on people with autoimmune hypothyroidism who underwent a thyroid surgery. They found that red/NIR light therapy improved thyroid hormone levels enough that they required, on average, roughly half as much thyroid hormone medication.
A 2003 study done in the Ukraine showed that red light therapy can decrease thyroid medication needs by 50-75% in people with postsurgical hypothyroidism.
A 2010 Russian dissertation study gave red light therapy on the thyroid gland to a group of people with hypothyroidism and found that 17% of people could completely get off thyroid medication and 38% could decrease the dose by 25-50µg.
A 2014 study used the light therapy for 10 sessions with 347 women with subclinical hypothyroidism. At baseline, the average TSH (thyroid stimulating hormone) was 9.1 mIU/L. (Note: Higher TSH is a sign of hypothyroidism). After ten sessions of light therapy, the TSH was normalized in 337 (97%) of these women. Their TSH averaged at 2.2 mIU/L after just 10 light treatments.
Heiskanen V. “Valtsu” (205). Hypothyroidism: Could it be treated with light? Valtsu’s.